XML 47 R36.htm IDEA: XBRL DOCUMENT v3.8.0.1
BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)
$ / shares in Units, $ in Millions
3 Months Ended
Mar. 31, 2018
USD ($)
$ / shares
Mar. 31, 2017
USD ($)
$ / shares
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Contract with Customer, Liability $ 412.3   $ 377.4  
Amortization of Deferred Sales Commissions 4.2 $ 3.7    
Assets, Current 2,896.6   2,733.8  
Assets, Noncurrent     13,939.2  
Net Cash Provided by (Used in) Operating Activities $ 154.7 $ 225.9    
Percent of Revenue Contributed 100.00% 100.00%    
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification $ 13.2      
Revenues 2,848.3 $ 2,413.7    
Cost of Revenue 2,069.3 1,701.2    
Gross Profit 779.0 712.5    
Selling, general and administrative expenses 397.0 342.9    
Nonoperating Income (Expense) (63.9) (52.8)    
Other Nonoperating Income   104.3    
Provision for income taxes 69.0 82.0    
Net earnings 172.5 183.3    
Less: Net earnings attributable to the noncontrolling interest 0.7 (0.3)    
Net Income (Loss) Attributable to Parent $ 173.2 $ 183.0    
Basic earnings per common share (in dollars per share) | $ / shares $ 1.70 $ 1.79    
Diluted earnings per common share (in dollars per share) | $ / shares $ 1.67 $ 1.75    
Net Cash Provided by (Used in) Investing Activities $ (74.3) $ (245.5)    
Net Cash Provided by (Used in) Financing Activities (40.0) (51.9)    
Effect of exchange rate changes on cash and cash equivalents 4.7 3.4    
Cash and Cash Equivalents, Period Increase (Decrease) 45.1 (68.1)    
Assets 16,831.7   16,673.0  
Liabilities, Current 2,104.0   2,185.7  
Liabilities, Noncurrent     7,662.4  
Common stock, 92.8 and 93.5 shares outstanding at March 31, 2013 and December 31, 2012, respectively 20.2   20.8  
Stockholders' Equity Attributable to Parent 6,984.0 5,653.2 6,804.1 $ 5,518.2
Liabilities and Equity 16,831.7   16,673.0  
Capitalized Contract Cost, Amortization 0.6 0.1    
Deferred Revenue, Revenue Recognized 71.0 55.1    
Revenue, Remaining Performance Obligation 3,900.0      
Contract with Customer, Performance Obligation Satisfied in Previous Period $ 22.1      
Ownership percentage below which investments are generally accounted for on the cost method (in thousandths) 20.00%      
LabCorp Diagnostics [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Revenue, Net   $ 1,639.7    
Percent of Revenue Contributed 62.10% 67.90%    
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification   $ 78.2    
Revenues $ 1,770.2      
Covance Drug Development [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Revenue, Net   $ 774.2    
Percent of Revenue Contributed 37.90% 32.10%    
Revenues $ 1,078.5      
Investigator fees [Member] | Covance Drug Development [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification 57.4      
Measure of progress [Member] | Covance Drug Development [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification 12.5      
sales commissions [Member] | Covance Drug Development [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification $ 1.4      
Previous Accounting Guidance [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Net cash provided by (used in) operating activities, as reported   $ 233.8    
Current assets, as reported     2,682.6  
Gross profit, as reported   803.6    
Noncurrent assets, as reported     13,885.4  
Total assets, as reported     16,568.0  
Net Cash Provided by (Used in) Investing Activities, as reported   (245.5)    
Revenues   2,447.0    
Cost of Revenue   1,643.4    
Selling, general and administrative expenses   419.4    
Nonoperating Income (Expense)   104.5    
Provision for income taxes   87.2    
Net income (loss), including portion attributable to NCI, as reported   192.5    
Less: Net earnings attributable to the noncontrolling interest   (0.3)    
Net income (loss) attributable to Parent, as reported   $ 192.2    
Basic earnings per common share (in dollars per share) | $ / shares   $ 1.87    
Diluted earnings per common share (in dollars per share) | $ / shares   $ 1.84    
Net Cash Provided by (Used in) Financing Activities, as reported   $ (59.8)    
Effect of Exchange Rate on Cash and Cash Equivalents, as reported   3.4    
Cash and Cash Equivalents, Period Increase (Decrease)   (68.1)    
Current liabilities, as reported     2,046.1  
Noncurrent liabilities, as reported     7,671.1  
Noncontrolling Interest Mezzanine Equity, as reported     20.8  
Shareholders Equity Attributable to Parent, as reported     6,830.0  
Total liabilities and shareholders equity, as reported     $ 16,568.0  
Other Current Assets [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   51.2    
Other Noncurrent Assets [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   53.8    
Assets [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   105.0    
Other Current Liabilities [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   139.6    
Other Noncurrent Liabilities [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   (8.7)    
Noncontrolling Interest [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   0.0    
Shareholders' Equity [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   (25.9)    
Total liabilities and shareholder's equity [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   105.0    
Revenue from Contract with Customer [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   (33.3)    
ASU 715 pension adjustment to previously reported amounts   0.0    
Gross profit [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   (91.1)    
ASU 715 pension adjustment to previously reported amounts   0.0    
Selling, General and Administrative Expenses [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   (76.8)    
ASU 715 pension adjustment to previously reported amounts   0.3    
Nonoperating Income (Expense) [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   0.1    
ASU 715 pension adjustment to previously reported amounts   (0.3)    
Provision for income taxes [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   (5.2)    
ASU 715 pension adjustment to previously reported amounts   0.0    
Net earnings [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   (9.2)    
ASU 715 pension adjustment to previously reported amounts   0.0    
Net earnings attributable to NCI [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   0.0    
ASU 715 pension adjustment to previously reported amounts   0.0    
Cost of Sales [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   57.8    
ASU 715 pension adjustment to previously reported amounts   0.0    
Net earnings attributable to company [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   (9.2)    
ASU 715 pension adjustment to previously reported amounts   0.0    
Net cash from operating activities [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   $ 0.0    
ASC 230 Cash flow presentation adjustment   (7,900,000)    
Net cash from investing activities [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   $ 0.0    
Net Cash Provided by (Used in) Investing Activities   0.0    
Net cash from financing activities [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   0.0    
Net Cash Provided by (Used in) Financing Activities   7.9    
Effect of exchange rate on cash and cash equivalents [Member]        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
ASU 606 adjustment to previously reported amounts   0.0    
Effect of exchange rate changes on cash and cash equivalents   $ 0.0